Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$51.6M Sell
2,775,111
-18,600
-0.7% -$411K 2% 5
2019
Q1
$78.8M Sell
2,793,711
-254,246
-8% -$7.41M 3.28% 2
2018
Q4
$85.8M Buy
3,047,957
+171,858
+6% +$5.57M 3.91% 1
2018
Q3
$105M Buy
2,876,099
+582,803
+25% +$21.9M 4.39% 1
2018
Q2
$82.9M Buy
2,293,296
+109,388
+5% +$4.29M 3.56% 1
2018
Q1
$90M Buy
2,183,908
+438,318
+25% +$18.7M 4.62% 1
2017
Q4
$73.7M Buy
+1,745,590
New +$66.7M 3.96% 1

Other funds holding VTRS

Delek Group's VTRS Position: Q2 2019 in Review

Delek Group reduced its Viatris (VTRS) stake by 0.67% in Q2 2019, selling an estimated $411K and leaving 2,775,111 shares worth $51.6M. The position accounts for 2% of the portfolio, ranked #5.

Delek Group first reported a position in VTRS in Q4 2017 and has held it in 7 quarters since. The position peaked at $105M in Q3 2018. 440 funds tracked by Wall St. Rank hold VTRS as of Q2 2019.

  • Delek Group held 2,775,111 shares of Viatris worth $51.6M as of Q2 2019.
  • Delek Group sold 18,600 Viatris shares in Q2 2019, an estimated $411K.
  • Viatris made up 2% of Delek Group's portfolio in Q2 2019, its #5 holding.
  • Delek Group first reported a position in Viatris in Q4 2017 and has held it in 7 quarters since.
  • Delek Group's Viatris position peaked at $105M in Q3 2018.
  • 440 funds tracked by Wall St. Rank held Viatris as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.